A Phase 1, Single Ascending Dose, Randomized, Double-Blind, Placebo and Positive Controlled Study to Evaluate the Cardiovascular Effect of Tetrodotoxin in Healthy Adult Subjects

NCT04083833 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

TQT Study

Interventions

DRUG: Tetrodotoxin
DRUG: Placebos

Sponsor

Wex Pharmaceuticals Inc.

Collaborators

[object Object]